Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia

Neurobiology of Disease

Volumn 71, Issue , 2014, Pages 24-33

  Prescott, I A ^a   Liu, L D ^a   Dostrovsky, J O ^a   Hodaie, M ^b,c   Lozano, A M ^b,c   Hutchison, W D ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Krembil Neuroscience Centre   (Canada)

Author keywords

Basal ganglia; Depotentiation; Globus pallidus; Microelectrodes; Parkinson's disease; Substantia nigra; Synaptic plasticity

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DEPOTENTIATION; DISEASE SEVERITY; DYSKINESIA; ELECTRIC POTENTIAL; ELECTROSTIMULATION; EVOKED RESPONSE; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; MICROELECTRODE; MIDDLE AGED; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; ACTION POTENTIAL; BIOPHYSICS; DRUG EFFECTS; DYSKINESIA, DRUG-INDUCED; NERVE CELL; NERVE CELL NETWORK; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS;

ACTION POTENTIALS; AGED; ANTIPARKINSON AGENTS; BASAL GANGLIA; BIOPHYSICAL PHENOMENA; DYSKINESIA, DRUG-INDUCED; ELECTRIC STIMULATION; FEMALE; HUMANS; LEVODOPA; MALE; MICROELECTRODES; MIDDLE AGED; NERVE NET; NEURONS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84906496404     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.08.002     Document Type: Article

References (34)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12:366-375.
2. Andersson D.R., Nissbrandt H., Bergquist F. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission. Eur. J. Neurosci. 2006, 24:617-624.
3. Arias-Montano J.A., Floran B., Floran L., Aceves J., Young J.M. Dopamine D(1) receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels. Synapse 2007, 61:310-319.
4. Calabresi P., Maj R., Pisani A., Mercuri N.B., Bernardi G. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci. 1992, 12:4224-4233.
5. Calabresi P., Di Filippo M., Ghiglieri V., Picconi B. Molecular mechanisms underlying levodopa-induced dyskinesia. Mov. Disord. 2008, 23(Suppl. 3):S570-S579.
6. Calabresi P., Mercuri N.B., Di Filippo M. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. Brain 2009, 132:285-287.
7. Calabresi P., Di Filippo M., Ghiglieri V., Tambasco N., Picconi B. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol. 2010, 9:1106-1117.
8. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990, 13:281-285.
9. Dostrovsky J.O., Levy R., Wu J.P., Hutchison W.D., Tasker R.R., Lozano A.M. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J. Neurophysiol. 2000, 84:570-574.
10. Fuller J., Prescott I.A., Moro E., Toda H., Lozano A., Hutchison W.D. Pallidal deep brain stimulation for a case of hemidystonia secondary to a striatal stroke. Stereotact. Funct. Neurosurg. 2013, 91:190-197.
11. Huang C.C., Liang Y.C., Hsu K.S. A role for extracellular adenosine in time-dependent reversal of long-term potentiation by low-frequency stimulation at hippocampal CA1 synapses. J. Neurosci. 1999, 19:9728-9738.
12. Hutchison W.D., Lozano A.M. Microelectrode recordings in movement disorder surgery. Prog. Neurol. Surg. 2000, 15:103-117.
13. Jaber M., Robinson S.W., Missale C., Caron M.G. Dopamine receptors and brain function. Neuropharmacology 1996, 35:1503-1519.
14. Lafreniere-Roula M., Hutchison W.D., Lozano A.M., Hodaie M., Dostrovsky J.O. Microstimulation-induced inhibition as a tool to aid targeting the ventral border of the subthalamic nucleus. J. Neurosurg. 2009, 111(4):724-728.
15. Levy R., Lozano A.M., Hutchison W.D., Dostrovsky J.O. Dual microelectrode technique for deep brain stereotactic surgery in humans. Neurosurgery 2007, 60:277-283. (discussion 283-4).
16. Nambu A. Globus pallidus internal segment. Prog. Brain Res. 2007, 160:135-150.
17. Nicholls R.E., Alarcon J.M., Malleret G., Carroll R.C., Grody M., Vronskaya S., Kandel E.R. Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility. Neuron 2008, 58:104-117.
18. Picconi B., Centonze D., Hakansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci. 2003, 6:501-506.
19. Picconi B., Paille V., Ghiglieri V., Bagetta V., Barone I., Lindgren H.S., Bernardi G., Angela C.M., Calabresi P. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol. Dis. 2008, 29:327-335.
20. Picconi B., Bagetta V., Ghiglieri V., Paillè V., Di Filippo M., Pendolino V., Tozzi A., Giampà C., Fusco F.R., Sgobio C., Calabresi P. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 2011, 134:375-387.
21. Picconi B., Piccoli G., Calabresi P. Synaptic dysfunction in Parkinson's disease. Adv. Exp. Med. Biol. 2012, 970:553-572.
22. Prescott I.A., Dostrovsky J.O., Moro E., Hodaie M., Lozano A.M., Hutchison W.D. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain 2009, 132:309-318.
23. Prescott I.A., Dostrovsky J.O., Moro E., Hodaie M., Lozano A.M., Hutchison W.D. Reduced paired pulse depression in the basal ganglia of dystonia patients. Neurobiol. Dis. 2013, 51:214-221.
24. Quik M., Chen L., Parameswaran N., Xie X., Langston J.W., McCallum S.E. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. J. Neurosci. 2006, 26:4681-4689.
25. Ribak C.E., Vaughn J.E., Roberts E. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry. J. Comp. Neurol. 1979, 187:261-283.
26. Ribak C.E., Vaughn J.E., Barber R.P. Immunocytochemical localization of GABAergic neurones at the electron microscopical level. Histochem. J. 1981, 13:555-582.
27. Richfield E.K., Young A.B., Penney J.B. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J. Comp. Neurol. 1987, 262:446-463.
28. Saliba R.S., Michels G., Jacob T.C., Pangalos M.N., Moss S.J. Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites. J. Neurosci. 2007, 27:13341-13351.
29. Seino S., Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol. Rev. 2005, 85:1303-1342.
30. Shink E., Smith Y. Differential synaptic innervation of neurons in the internal and external segments of the globus pallidus by the. J. Comp. Neurol. 1995, 358:119-141.
31. Smith Y., Kieval J.Z. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci. 2000, 23:S28-S33.
32. Wickens J.R., Reynolds J.N.J., Hyland B.I. Neural mechanisms of reward-related motor learning. Curr. Opin. Neurobiol. 2003, 13:685-690.
33. Yung K.K., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J., Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 1995, 65:709-730.
34. Zhuo M., Zhang W., Son H., Mansuy I., Sobel R.A., Seidman J., Kandel E.R. A selective role of calcineurin aalpha in synaptic depotentiation in hippocampus. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4650-4655.